Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05740644 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of the Zynex Monitoring System, Model CM-1600
A NA study, sponsored by Zynex Monitoring Solutions.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05740644 is a NA study that has completed, run by Zynex Monitoring Solutions. The registered enrollment target is 20 participants.
The verdict
NCT05740644, a NA study, has completed, sponsored by Zynex Monitoring Solutions.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a prospective, single-arm, non-randomized, non-controlled single-center study for the evaluation of the Zynex CM-1600 in 20 healthy adults undergoing a manual blood loss of up to 500mL followed by an infusion of 1 liter of normal saline.
Interventions
- DEVICE CM-1600
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-02-13 |
| Est. Completion | 2023-02-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05740644
The ClinicalTrials.gov registry entry for NCT05740644 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zynex Monitoring Solutions, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CM-1600 is the first listed.
NCT05740644 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05740644 about?
NCT05740644 is a clinical study titled "Clinical Evaluation of the Zynex Monitoring System, Model CM-1600". This is a prospective, single-arm, non-randomized, non-controlled single-center study for the evaluation of the Zynex CM-1600 in 20 healthy adults undergoing a manual blood loss of up to 500mL followed by an infusion of 1 liter of normal saline.
What is the current status of trial NCT05740644?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2023-02-13. Estimated completion is 2023-02-22.
What interventions are being tested in trial NCT05740644?
The interventions under investigation include: CM-1600 (DEVICE).
Who is sponsoring clinical trial NCT05740644?
This trial is sponsored by Zynex Monitoring Solutions, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.